1 document found, page 1 of 1

Sort by Issue Date
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

Renal impairment at presentation is not an adverse prognostic factor in multipl...

Neves,Manuel; Martins,Helena; Esteves,Graca; Espada,Eduardo; Pereira,Isabel; Martins,Carlos; Carmo,Jose Alves Do

Fifteen to forty per cent of multiple myeloma patients have renal impairment at diagnosis. The Durie-Salmon staging included renal impairment as an adverse prognostic factor and so does the International Staging System, since β2-microglobulin correlates with both tumour burden and renal impairment. However, the introduction of new therapeutic agents (as bortezomib, lenalidomide, and thalidomide) and new prognos...

Date: 2014   |   Origin: SciELO Portugal
More info.
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

1 Results

Queried text

Refine Results

Author








Date


Document Type


Access rights


Resource


Subject